Due to the incoming snowstorm, RPC2B will be closed on Tuesday, February 13th. We apologize for the inconvenience and hope to be operating again tomorrow.

Educational

  1. July 26, 2024

    Understanding the Differences Between 503A and 503B Compounding Pharmacies

    By The Revelation Pharma Marketing Team / Lexi J., BHA., MBA (Marketing Assoc. of Patient Partnerships), Haleigh Wilkes, PharmD., & Joseph Drummond, PharmD.

    In the world of pharmaceuticals, compounding pharmacies play a critical role in tailoring medications to meet the unique needs of patients. But not all compounding pharmacies are created equal. There are two primary types: 503A and 503B. Understanding the differences between these two can help you make more informed decisions about your healthcare. In this article, we'll break down these distinctions and explore the relevance of this topic to Revelation Pharma and the communities we serve.

     

    Understanding 503A and 503B Compounding Pharmacies

    The distinction between 503A and 503B compounding pharmacies stems from the Drug Quality and Security Act (DQSA) of 2013. This act was introduced to enhance the safety and quality of compounded medications.

     

    Read More
  2. April 18, 2024

    Podcast: Clearing the air on compounding GLP1 drugs

    The whole issue of compounding GLP-1 agonists like semaglutide is fraught with land mines and misinformation — disinformation, even.

    It's good, then, that the Game Changers Pharmacotherapy Podcast had a couple of guests who know what they're talking about to clear some of the air: Tenille Davis, PharmD, RPh (chief advocacy officer for the Alliance for Pharmacy Compounding) and Scott Brunner, CAE (CEO of APC). The host — Geoff Wall, PharmD — has the chops, too; he's a professor of pharmacy practice at Drake University.

    It covers everything you need to know about compounding GLP-1s, including access, cost, and how shortages come into play. Even better, you might be able to get a half-hour of CPE credit, too!

    Check out "Compounded GLP1s" on the Game Changers podcast — click

    Read More
  3. February 27, 2024

    A Guide to Writing a Compounded Prescription for Hormone Replacement Therapy (HRT)

    Zoom-header2

    Hormone Replacement Therapy (HRT) is a treatment option widely prescribed for patients experiencing various symptoms related to hormonal imbalances. Compounded prescriptions for HRT allow healthcare practitioners to tailor medications specific to individual patient’s needs, providing a more personalized approach

    Read More
  4. November 01, 2023

    Important USP changes — what you need to know

    Some important updates regarding quality standards and changes to the United States Pharmacopeia (USP) standards are coming that may impact your practice.

    To give some background, pharmacies in the Revelation Pharma Network follow standard operating procedures that are built around processes developed by USP. While USP is not a regulatory agency and does not carry the force of law, many state boards of pharmacy as well as the FDA recognize USP’s compounding standards as the measure of quality assurance that a compounding pharmacy should follow.

    On November 1, 2023, new editions of USP chapters pertaining to nonsterile, sterile, and hazardous drug compounding will become compendially applicable, meaning that they are the most current versions and regulatory agencies may choose to adopt them.

    It is important to note that these new editions are not simple modifications but are largely complete re-writes of the current

    Read More
Page